Latest Period
Q1 2026
Security Snapshot
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) Institutional Ownership
CUSIP: 413197104
13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026
Institutions Reporting
305
Shares (Excl. Options)
55,521,997
Price
$28.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- HRMY on Nasdaq
- Shares outstanding
- 57,644,670
- Price per share
- $30.80
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 55,521,997
- Total reported value
- $1,555,474,024
- % of total 13F portfolios
- 0%
- Share change
- +5,328,818
- Value change
- +$124,878,297
- Number of holders
- 305
- Price from insider filings
- $30.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- HRMY - Harmony Biosciences Holdings, Inc. - Common Stock is tracked under CUSIP 413197104.
- 305 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 322 to 305 between Q4 2025 and Q1 2026.
- Reported value moved from $1,866,203,572 to $1,555,474,024.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 305 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 413197104:
Significant Owners of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Marshman Fund Trust II | 11% | $178,084,462 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| BlackRock, Inc. | 10% | -18% | $169,781,023 | -$35,290,072 | 5,768,978 | -17% | BlackRock, Inc. | 31 Mar 2025 |
| FMR LLC | 5.4% | -19% | $116,481,431 | -$27,472,267 | 3,112,812 | -19% | FMR LLC | 31 Dec 2025 |
As of 31 Mar 2026, 305 institutional investors reported holding 55,521,997 shares of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY). This represents 96% of the company’s total 57,644,670 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 7,070,035 | -0.26% | 0% | $198,031,682 |
| FMR LLC | 5.5% | 3,157,639 | +1.4% | 0% | $88,445,461 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7% | 2,714,353 | 0% | 0% | $76,029,028 |
| AMERICAN CENTURY COMPANIES INC | 3.7% | 2,105,179 | +14% | 0.03% | $58,966,064 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 2,102,315 | 0% | 0% | $58,885,843 |
| DIMENSIONAL FUND ADVISORS LP | 3.6% | 2,076,510 | +13% | 0.01% | $58,157,110 |
| LSV ASSET MANAGEMENT | 3.5% | 2,025,143 | +22% | 0.12% | $56,724,000 |
| SG Americas Securities, LLC | 3.5% | 2,018,174 | +110% | 0.06% | $56,529,000 |
| STATE STREET CORP | 3.1% | 1,784,362 | +7.4% | 0% | $49,979,980 |
| ARMISTICE CAPITAL, LLC | 2.8% | 1,624,000 | +225% | 1.5% | $45,488,240 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.4% | 1,382,113 | -7.3% | 0.02% | $38,712,985 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,322,720 | +4.1% | 0% | $37,054,782 |
| GOLDMAN SACHS GROUP INC | 2.1% | 1,239,207 | +118% | 0% | $34,710,189 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 1,077,371 | +0.64% | 0.05% | $30,177,162 |
| MORGAN STANLEY | 1.8% | 1,031,018 | +26% | 0% | $28,878,819 |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 954,359 | +312% | 0.02% | $26,731,596 |
| JPMORGAN CHASE & CO | 1.4% | 823,513 | +313% | 0% | $22,152,500 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 733,443 | +254% | 0.02% | $20,543,738 |
| AQR CAPITAL MANAGEMENT LLC | 1.2% | 716,246 | -12% | 0.01% | $20,062,050 |
| Invesco Ltd. | 1.1% | 628,247 | +39% | 0% | $17,597,198 |
| Trexquant Investment LP | 1% | 594,850 | +99% | 0.12% | $16,661,749 |
| CITADEL ADVISORS LLC | 1% | 585,623 | +39% | 0.01% | $16,403,300 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.98% | 567,115 | +24% | 0.01% | $15,884,891 |
| BNP PARIBAS FINANCIAL MARKETS | 0.95% | 545,188 | 0% | 0.01% | $15,270,716 |
| NOMURA HOLDINGS INC | 0.9% | 520,947 | +2.1% | 0.15% | $14,591,725 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 55,521,997 | $1,555,474,024 | +$124,878,297 | $28.01 | 305 |
| 2025 Q4 | 49,889,376 | $1,866,203,572 | +$93,866,777 | $37.42 | 322 |
| 2025 Q3 | 47,339,126 | $1,304,886,690 | -$112,498,749 | $27.56 | 292 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,889 | $31.60 | 276 |
| 2025 Q1 | 50,193,424 | $1,664,235,088 | -$100,697,267 | $33.19 | 267 |
| 2024 Q4 | 52,708,406 | $1,813,638,877 | +$62,320,767 | $34.41 | 244 |
| 2024 Q3 | 50,136,635 | $2,005,018,440 | +$11,121,046 | $40.00 | 231 |
| 2024 Q2 | 50,163,988 | $1,513,604,428 | +$34,652,893 | $30.17 | 218 |
| 2024 Q1 | 48,982,561 | $1,644,752,000 | +$41,053,934 | $33.58 | 206 |
| 2023 Q4 | 47,832,583 | $1,544,993,160 | -$51,074,763 | $32.30 | 219 |
| 2023 Q3 | 49,527,453 | $1,623,105,557 | -$85,461,798 | $32.77 | 203 |
| 2023 Q2 | 51,951,129 | $1,828,229,880 | +$28,751,282 | $35.19 | 207 |
| 2023 Q1 | 51,270,566 | $1,674,006,219 | -$29,571,258 | $32.65 | 213 |
| 2022 Q4 | 51,015,535 | $2,810,596,096 | +$34,893,529 | $55.10 | 238 |
| 2022 Q3 | 50,461,165 | $2,237,024,113 | +$91,703,030 | $44.29 | 195 |
| 2022 Q2 | 47,874,920 | $2,335,182,718 | +$99,684,851 | $48.77 | 173 |
| 2022 Q1 | 45,933,803 | $2,235,023,234 | +$79,981,090 | $48.65 | 168 |
| 2021 Q4 | 44,541,354 | $1,899,444,678 | +$107,131,256 | $42.64 | 138 |
| 2021 Q3 | 30,932,269 | $1,185,850,908 | +$116,456,188 | $38.33 | 99 |
| 2021 Q2 | 27,994,218 | $790,282,400 | -$7,611,822 | $28.23 | 79 |
| 2021 Q1 | 27,468,517 | $907,561,000 | -$18,485,709 | $33.04 | 55 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,367 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,000 | $33.90 | 44 |